Treatment for age-related macular degeneration and other...

Details Treatment for age-related macular degeneration and other... Treatment for age-related macular degeneration and other...

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61P 27/06 (2006.01)

Patent

CA 2666843

A method is disclosed for treating diseases or disorders of the eye involving undesired neovascularization by administration of a complement inhibitory protein such as soluble complement receptor type I (sCRl). The present invention relates to the direct treatment of macular degeneration, particularly age-related macular degeneration (AMD), by administering a complement inhibitory protein intraocularly or systemically.

L'invention concerne une méthode de traitement de maladies ou de troubles oculaires associés à une néovascularisation par administration d'une protéine d'inhibition de complément telle que le récepteur de complément soluble de type 1 (sCR1). La présente invention concerne le traitement direct de la dégénération maculaire, en particulier de la dégénération maculaire associée au vieillissement (AMD), par administration d'une protéine d'inhibition complémentaire par voie intraoculaire ou systémique.

Affiliated with

Also associated with

Rating

Treatment for age-related macular degeneration and other... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for age-related macular degeneration and other..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for age-related macular degeneration and other... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1892286